These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients. Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197 [TBL] [Abstract][Full Text] [Related]
57. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke. Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266 [TBL] [Abstract][Full Text] [Related]
58. Management of ischaemic stroke: statins and antiplatelet agents. Cimminiello C; Romano A Neurol Sci; 2005 May; 26 Suppl 1():S24-5. PubMed ID: 15883685 [No Abstract] [Full Text] [Related]
59. [Antagonists of platelet P2 receptors: achievements, problems, and prospects]. Ziganshin AY Eksp Klin Farmakol; 2010 Apr; 73(4):38-43. PubMed ID: 20486559 [TBL] [Abstract][Full Text] [Related]
60. [Platelet activity and the fibrinolytic system of blood in cerebral ischemia]. Jovicić A; Malesević M Med Pregl; 1982; 35(5-6):185-9. PubMed ID: 7177059 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]